NCT02771574: Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia
- State
- Completed
- Phase
- Phase 2
- People
- 19 taking part
- Started
- May 2016
- Primary completion
- Jun 2017
- Arms
- Part A: Lyo avexitide 0.05 mg/kg, Part A: Lyo avexitide 0.15 mg/kg, Part A: Lyo avexitide 0.35 mg/kg, Part A: Lyo avexitide 0.46 mg/kg, Part B: Liq avexitide 0.38 (±0.03) mg/kg
- Results
- Posted on the registry
- 13 May 2016: Trial registered
- 14 Aug 2020: Trial results posted